<code id='EB3B69EAED'></code><style id='EB3B69EAED'></style>
    • <acronym id='EB3B69EAED'></acronym>
      <center id='EB3B69EAED'><center id='EB3B69EAED'><tfoot id='EB3B69EAED'></tfoot></center><abbr id='EB3B69EAED'><dir id='EB3B69EAED'><tfoot id='EB3B69EAED'></tfoot><noframes id='EB3B69EAED'>

    • <optgroup id='EB3B69EAED'><strike id='EB3B69EAED'><sup id='EB3B69EAED'></sup></strike><code id='EB3B69EAED'></code></optgroup>
        1. <b id='EB3B69EAED'><label id='EB3B69EAED'><select id='EB3B69EAED'><dt id='EB3B69EAED'><span id='EB3B69EAED'></span></dt></select></label></b><u id='EB3B69EAED'></u>
          <i id='EB3B69EAED'><strike id='EB3B69EAED'><tt id='EB3B69EAED'><pre id='EB3B69EAED'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:256
          Christine Kao/STAT

          There’s a specter haunting Wall Street.

          It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

          advertisement

          Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more
          Kidney transplant patients stopped immunosuppressants in trial
          Kidney transplant patients stopped immunosuppressants in trial

          BRENDANSMIALOWSKI/AFP/GettyImagesKidneytransplantsarethemostcommonorgantransplantprocedureintheU.S.,

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Kaiser Permanente unions announce official strike date

          AdobeYou’rereadingthewebeditionofHealthCareInc.,STAT’sweeklynewsletterfollowingtheflowofmoneythrough